169 related articles for article (PubMed ID: 20621554)
1. Evaluation of core and NS4B synthetic peptide-based immunoassays for the detection of hepatitis C virus antibodies in clinical samples from Cameroon, Central Africa.
Njouom R; Nerrienet E; Budkowska A; Maillard P; Rousset D; Kalinina O; Mavromara P;
J Clin Virol; 2010 Sep; 49(1):61-4. PubMed ID: 20621554
[TBL] [Abstract][Full Text] [Related]
2. Genotype dependence of peptide-based immunoassays for the detection of HCV core antibodies.
Muerhoff AS; Gutierrez R; Kyrk C; Leary T; Schlauder G; Dawson G; Desai SM
J Med Virol; 2008 Mar; 80(3):411-8. PubMed ID: 18205228
[TBL] [Abstract][Full Text] [Related]
3. Quantitative antibody responses to structural (Core) and nonstructural (NS3, NS4, and NS5) hepatitis C virus proteins among seroconverting injecting drug users: impact of epitope variation and relationship to detection of HCV RNA in blood.
Beld M; Penning M; van Putten M; Lukashov V; van den Hoek A; McMorrow M; Goudsmit J
Hepatology; 1999 Apr; 29(4):1288-98. PubMed ID: 10094977
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human immune response to potential hepatitis C viral epitopes.
Khanna A; Poduri CD; Murugan P; Kumar S; Sugunan VS; Shenoy KT; Das MR
Acta Virol; 1998 Jun; 42(3):141-5. PubMed ID: 9842443
[TBL] [Abstract][Full Text] [Related]
5. Use of overlapping synthetic peptides to characterize samples from blood donors with indeterminate results to hepatitis C virus core antigen.
León P; López JA; Elola C; Lee SR; Calmann M; Echevarría JM
Vox Sang; 1998; 75(1):32-6. PubMed ID: 9745151
[TBL] [Abstract][Full Text] [Related]
6. Expression of the full-length HCV core subgenome from HCV gentoype-1a and genotype-3a and evaluation of the antigenicity of translational products.
Ansari MA; Irshad M; Agarwal SK; Chosdol K
Eur J Gastroenterol Hepatol; 2013 Jul; 25(7):806-13. PubMed ID: 23442416
[TBL] [Abstract][Full Text] [Related]
7. Comparison of prevalence of anti-hepatitis C virus antibodies in differing South American populations.
Robinson JW; Rosas M; Guzman F; Patarroyo ME; Moreno A
J Med Virol; 1996 Oct; 50(2):188-92. PubMed ID: 8915886
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals.
Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G
J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactivity of HCV/HBV epitopes displayed in an epitope-presenting system.
Chen Y; Xiong X; Liu X; Li J; Wen Y; Chen Y; Dai Q; Cao Z; Yu W
Mol Immunol; 2006 Feb; 43(5):436-42. PubMed ID: 16337486
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay.
Alzahrani AJ
J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of a panel of monoclonal antibodies raised against recombinant HCV core protein.
Ferns RB; Tuke PW; Sweenie CH
J Med Virol; 1996 Nov; 50(3):221-9. PubMed ID: 8923286
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the antibody reactivity to synthetic peptides from different parts of the hepatitis C virus genome.
Pujol FH; Khudyakov YE; Devesa M; León G; Blitz-Dorfman L; Monsalve F; Lambert SB; Kalinina TY; Liprandi F; Fields HA
Viral Immunol; 1996; 9(2):89-96. PubMed ID: 8822625
[TBL] [Abstract][Full Text] [Related]
13. Simultaneous detection of hepatitis C virus antigen and antibodies in dried blood spots.
Brandão CP; Marques BL; Marques VA; Villela-Nogueira CA; Do Ó KM; de Paula MT; Lewis-Ximenez LL; Lampe E; Sá Ferreira JA; Villar LM
J Clin Virol; 2013 Jun; 57(2):98-102. PubMed ID: 23518440
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients.
Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B
J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976
[TBL] [Abstract][Full Text] [Related]
15. [Synthesis and antigenic activity of peptides from core- and NS3-proteins of hepatitis C virus].
Semiletov IuA; Firsova TV; Shibnev VA; Viazov SO
Bioorg Khim; 1993 Jan; 19(1):126-9. PubMed ID: 8387305
[TBL] [Abstract][Full Text] [Related]
16. Simultaneous detection of anti-HCV antibody and HCV core antigen.
Ansaldi F; Icardi G
Methods Mol Biol; 2009; 510():15-23. PubMed ID: 19009250
[TBL] [Abstract][Full Text] [Related]
17. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters.
Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B
Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640
[TBL] [Abstract][Full Text] [Related]
18. [HCV associated antibodies (anti-HCV, anti-HCV core, anti-C14, anti-NS)].
Ishikawa K; Koyama T; Isobe N
Nihon Rinsho; 2010 Jun; 68 Suppl 6():446-9. PubMed ID: 20942100
[No Abstract] [Full Text] [Related]
19. [Spontaneous HCV clearance: an association with gender, age, viral genotypes, infection transmission routes, and markers of HBV and HIV].
Fedorchenko SV; Martynovich TL; Liashok OV; Kariuk ZhA; Ianchenko VI
Ter Arkh; 2010; 82(3):52-6. PubMed ID: 20564924
[TBL] [Abstract][Full Text] [Related]
20. Assessment of specific antibodies to F protein in serum samples from Chinese hepatitis C patients treated with interferon plus ribavarin.
Gao DY; Zhang XX; Hou G; Jin GD; Deng Q; Kong XF; Zhang DH; Ling Y; Yu DM; Gong QM; Zhan Q; Yao BL; Lu ZM
J Clin Microbiol; 2008 Nov; 46(11):3746-51. PubMed ID: 18832124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
